SCHEMBL7989207

SCHEMBL7989207

CCCO[C@H]1CC[C@@](CS)(C(=O)N[C@@H](Cc2ccccc2)C(=O)NC)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985458 0.92 MMP1 (0.86) MMP1
SCHEMBL7064472 0.92 MMP1 (1.00) MMP1
SCHEMBL7064613 0.92 MMP1 (1.00) MMP1
SCHEMBL7985530 0.88 MMP1 (1.00) MMP1
SCHEMBL7985520 0.85 MMP1 (0.75) MMP1
SCHEMBL7985712 0.85 MMP1 (1.00) MMP1
SCHEMBL7985711 0.85 MMP1 (1.00) MMP1
SCHEMBL7985544 0.83 MMP1 (1.00) MMP1
SCHEMBL8166286 0.83 MMP1 (1.00) MMP1
SCHEMBL8166290 0.83 MMP1 (1.00) MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201133-B1 FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS, TREATING TNF ALPHA AND MATRIX METALLOPROTEINASE DEPENDENT DISEASES OR CONDITIONS, CANCER NOVARTIS AG (CH) 2001-03-13 US disclosed
US-6034136-A METALLOPROTEINASE INHIBITOR NOVARTIS AG (CH) 2000-03-07 US disclosed